CureSearch for Children’s Cancer this week announced the recipients of its Acceleration Initiative grants, awarding $5 million to children’s cancer researchers studying areas critical to achieving breakthroughs in treatments and with the potential to reach patients in early clinical trials within three years. New treatments are important because 40,000 children undergo cancer treatment each year, and cancer remains the leading cause of death by disease in children.
“Working with our Scientific Advisory Council, we identified three grand challenges that represent research barriers that need to be overcome in order to truly advance the field and create a lasting impact for kids with cancer,” says Laura Thrall, president and CEO of CureSearch. “We are thrilled to be funding research with patient-centric outcomes that not only addresses unmet needs but also uses innovative and novel approaches to do so.”
The first ‘grand challenge’ invited investigators to develop novel approaches to treating metastatic disease (when cancer spreads to new locations in the body), with the potential for broad applicability to multiple cancers and/or patient populations, that have a high probability of clinical application within 3 years.